Analysts: Orexigen Therapeutics Inc (OREX.OQ)
OREX.OQ on NASDAQ Stock Exchange Global Select Market
7.55USD
3:32pm EDT
7.55USD
3:32pm EDT
Price Change (% chg)
$0.01 (+0.20%)
$0.01 (+0.20%)
Prev Close
$7.54
$7.54
Open
$7.51
$7.51
Day's High
$7.66
$7.66
Day's Low
$7.46
$7.46
Volume
160,108
160,108
Avg. Vol
337,439
337,439
52-wk High
$7.84
$7.84
52-wk Low
$3.77
$3.77
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Outperform | -0.18 | December | 2 Aug 2013 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 2 | 2 | 2 | 2 |
| (2) OUTPERFORM | 4 | 4 | 4 | 4 |
| (3) HOLD | 2 | 2 | 2 | 2 |
| (4) UNDERPERFORM | 0 | 0 | 0 | 0 |
| (5) SELL | 0 | 0 | 0 | 0 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 2.00 | 2.00 | 2.00 | 2.00 |
Consensus Estimates Analysis
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-13 | 8 | 0.90 | 1.00 | 0.86 | 0.90 |
| Quarter Ending Dec-13 | 8 | 0.90 | 1.00 | 0.85 | 0.90 |
| Year Ending Dec-13 | 8 | 3.36 | 3.43 | 3.00 | 3.41 |
| Year Ending Dec-14 | 8 | 40.39 | 156.49 | 3.00 | 5.73 |
| Earnings (per share) | |||||
| Quarter Ending Sep-13 | 8 | -0.18 | -0.14 | -0.20 | -0.24 |
| Quarter Ending Dec-13 | 8 | -0.20 | -0.15 | -0.26 | -0.25 |
| Year Ending Dec-13 | 8 | -0.79 | -0.68 | -0.83 | -0.86 |
| Year Ending Dec-14 | 8 | -0.25 | 0.72 | -0.80 | -0.79 |
Historical Surprises
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Mar-13 | 0.89 | 0.86 | 0.03 | 3.86 |
| Quarter Ending Dec-12 | 0.91 | 0.86 | 0.05 | 5.62 |
| Quarter Ending Sep-12 | 0.89 | 0.86 | 0.03 | 3.50 |
| Quarter Ending Jun-12 | 0.89 | 0.86 | 0.03 | 3.29 |
| Quarter Ending Mar-12 | 0.90 | 0.86 | 0.05 | 5.07 |
| Earnings (per share) | ||||
| Quarter Ending Mar-13 | -0.34 | -0.21 | 0.13 | -38.51 |
| Quarter Ending Dec-12 | -0.44 | -0.41 | 0.03 | -6.29 |
| Quarter Ending Sep-12 | -0.30 | -0.44 | 0.14 | -48.80 |
| Quarter Ending Jun-12 | -0.17 | -0.25 | 0.08 | -45.60 |
| Quarter Ending Mar-12 | -0.12 | -0.16 | 0.04 | -31.47 |
Consensus Estimates Trend
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-13 | 0.90 | 0.90 | 0.89 | 0.89 | 0.90 |
| Quarter Ending Dec-13 | 0.90 | 0.90 | 0.89 | 0.89 | 0.90 |
| Year Ending Dec-13 | 3.36 | 3.36 | 3.36 | 3.36 | 3.41 |
| Year Ending Dec-14 | 40.39 | 40.39 | 40.39 | 40.39 | 5.73 |
| Earnings (per share) | |||||
| Quarter Ending Sep-13 | -0.18 | -0.18 | -0.18 | -0.18 | -0.24 |
| Quarter Ending Dec-13 | -0.20 | -0.20 | -0.20 | -0.20 | -0.25 |
| Quarter Ending Dec-13 | -0.79 | -0.79 | -0.79 | -0.79 | -0.86 |
| Quarter Ending Dec-14 | -0.25 | -0.25 | -0.25 | -0.25 | -0.79 |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Sep-13 | 0 | 0 | 1 | 0 |
| Quarter Ending Dec-13 | 0 | 0 | 1 | 0 |
| Year Ending Dec-13 | 0 | 0 | 0 | 1 |
| Year Ending Dec-14 | 0 | 0 | 1 | 0 |
| Earnings | ||||
| Quarter Ending Sep-13 | 0 | 0 | 0 | 0 |
| Quarter Ending Dec-13 | 0 | 0 | 0 | 0 |
| Year Ending Dec-13 | 0 | 0 | 0 | 0 |
| Year Ending Dec-14 | 0 | 0 | 0 | 0 |
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: ValuEngine, Inc.
|
$25.00
|
|
Provider: S&P Capital IQ Quantitative Report
|
$69.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Earnings vs.
Estimates